Deficits in executive functions (EF) are strongly related to real-life functioning and negative symptoms (NS) in schizophrenia. Recently, virtual reality has enabled more ecologically valid approaches to assess EF in simulated “real-life” scenarios among which the virtual cooking task (VCT) has gained attention. However, the clinical implications of the VCT in schizophrenia have not been investigated exhaustively. In this study, clinically stable individuals with schizophrenia (n = 38) and healthy controls (n = 42) completed a novel VCT and a set of computerized standard EF tools (CST) to primarily investigate concurrent and discriminant validity. In addition, the study explored links between EF assessments, functioning, and NS while controlling for antipsychotic intake, clinical stability, and age. This VCT consisted of four tasks with increasing difficulty and time constraints. The most relevant findings indicate that (1) the VCT showed moderate to strong correlations with CST, (2) the VCT discriminated EF performance between both the groups, (3) the VCT predicted interpersonal functioning, and (4) the VCT predicted NS in greater extent than CST. Accordingly, the findings give support to the concurrent and discriminant validity of the VCT to assess EF and indicate its value to deepen the study of collateral functional deficits and NS in schizophrenia.
Get full access to this article
View all access options for this article.
References
1.
TammingaCA. Domains of dysfunction in schizophrenia: Implications for diagnosis. World Psychiatry, 2008; 7(1):34–35; doi: 10.1002/j.2051-5545.2008.tb00147.x
2.
GBD 2019 Mental Disorders Collaborators. Global, regional, and national burden of 12 mental disorders in 204 countries and territories, 1990–2019: A systematic analysis for the Global Burden of disease study 2019. Lancet Psychiatry, 2022; 9(2):137–150; doi: 10.1016/S2215-0366(21)00395-3
SuchyY, ZiemnikRE, NiermeyerMA. Assessment of Executive Functions in Clinical Settings. Elsevier Inc.; Amsterdam. 2017; doi: 10.1016/B978-0-12-803676-1.00022-2
5.
ParseyCM, Schmitter-EdgecombeM. Applications of technology in neuropsychological assessment. Clin Neuropsychol, 2013; 27(8):1328–1361; doi: 10.1080/13854046.2013.834971
6.
ReichenbergA, HarveyPD. Neuropsychological impairments in schizophrenia: Integration of performance-based and brain imaging findings. Psychol Bull, 2007; 133(5):833–858; doi: 10.1037/0033-2909.133.5.833
7.
WeickertTW, GoldbergTE, GoldJM, et al.Cognitive impairments in patients with schizophrenia displaying preserved and compromised intellect. Arch Gen Psychiatry, 2000; 57(9):907–913; doi: 10.1001/archpsyc.57.9.907
8.
OrellanaG, SlachevskyA. Executive functioning in schizophrenia. Front Psychiatry, 2013; 4:15–35; doi: 10.3389/fpsyt.2013.00035
9.
DiamondA. Executive functions. Annu Rev Psychol, 2013; 64:135–168; doi: 10.1146/annurev-psych-113011-143750
DonohoeG, RobertsonIH. Can specific deficits in executive functioning explain the negative symptoms of schizophrenia? A review. Neurocase, 2003; 9(2):97–108; doi: 10.1076/NEUR.9.2.97.15075
12.
GreenMF, HarveyPD. Cognition in schizophrenia: Past, present, and future. Schizophr Res Cogn, 2014; 1(1):e1–e9; doi: 10.1016/J.SCOG.2014.02.001
13.
JuradoMB, RosselliM. The elusive nature of executive functions: A review of our current understanding. Neuropsychol Rev, 2007; 17(3):213–233; doi: 10.1007/S11065-007-9040-Z
14.
DibbenCRM, RiceC, LawsK, et al.Is executive impairment associated with schizophrenic syndromes? A meta-analysis. Psychol Med, 2009; 39(3):381–392; doi: 10.1017/S0033291708003887
15.
BowieCR, HarveyPD. Cognitive deficits and functional outcome in schizophrenia profile of cognitive impairments in schizophrenia. Neuropsychiatr Dis Treat, 2006; 2(4):531–536; doi: 10.2147/nedt.2006.2.4.531
16.
StroopJR. Studies of interference in serial verbal reactions. J Exp Psychol, 1935; 18(6):643–662; doi: 10.1037/h0054651
17.
ChaytorN, Schmitter-EdgecombeM, BurrR. Improving the ecological validity of executive functioning assessment. Arch Clin Neuropsychol, 2006; 21(3):217–227; doi: 10.1016/j.acn.2005.12.002
18.
BurgessPW, AldermanN, ForbesC, et al.The case for the development and use of “ecologically valid” measures of executive function in experimental and clinical neuropsychology. J Int Neuropsychol Soc, 2006; 12(2):194–209; doi: 10.1017/S1355617706060310
19.
ChaytorN, Schmitter-EdgecombeM. The ecological validity of neuropsychological tests. Neuropsychol Rev, 2003; 13(4):181–197; doi: 10.1023/b:nerv.0000009483.91468.fb
20.
KuJ, ChoWG, KimJH, et al.The development of a VR system for the cognitive and behavioral assessment of schizophrenia. Stud Health Technol Inform, 2004; 98:180–182; doi: 10.3233/978-1-60750-942-4-180
21.
KuJ, ChoW, KimJ-J, et al.A virtual environment for investigating schizophrenic patients’ characteristics: Assessment of cognitive and navigation ability. Cyberpsychol Behav, 2003; 6(4):397–404; doi: 10.1089/109493103322278781
22.
TyburskiE, MakM, SokołowskiA, et al.Executive dysfunctions in schizophrenia: A critical review of traditional, ecological, and virtual reality assessments. J Clin Med, 2021; 10(13):1–26; doi: 10.3390/jcm10132782
23.
LarøiF, CanlaireJ, MouradH, et al.Relations between a computerized shopping task and cognitive tests in a group of persons diagnosed with schizophrenia compared with healthy controls. J Int Neuropsychol Soc, 2010; 16(1):180–189; doi: 10.1017/S1355617709991159
24.
JosmanN, SchenirdermanAE, KlingerE, et al.Using virtual reality to evaluate executive functioning among persons with schizophrenia: A validity study. Schizophr Res, 2009; 115(2–3):270–277; doi: 10.1016/j.schres.2009.09.015
25.
PlechatáA, HejtmánekL, FajnerováI., Virtual supermarket shopping task for cognitive rehabilitation and assessment of psychiatric patients: Validation in chronic schizophrenia. Cesk Psychol, 2021; 65(1):14–30; doi: 10.51561/cspsych.65.1.14
26.
BakerEK, KurtzMM, AsturRS. Virtual reality assessment of medication compliance in patients with schizophrenia. Cyberpsychol Behav, 2006; 9(2):224–229; doi: 10.1089/cpb.2006.9.224
27.
KurtzMM, BakerE, PearlsonGD, et al.A virtual reality apartment as a measure of medication management skills in patients with schizophrenia: A pilot study. Schizophr Bull, 2007; 33(5):1162–1170; doi: 10.1093/schbul/sbl039
28.
SiddiquiI, SaperiaS, FervahaG, et al.Goal-directed planning and action impairments in Schizophrenia evaluated in a virtual environment. Schizophr Res, 2019; 206:400–406; doi: 10.1016/j.schres.2018.10.012
29.
LaloyauxJ, Van der LindenM, LevauxMN, et al.Multitasking capacities in persons diagnosed with schizophrenia: A preliminary examination of their neurocognitive underpinnings and ability to predict real world functioning. Psychiatry Res, 2014; 217(3):163–170; doi: 10.1016/j.psychres.2014.03.026
30.
LaloyauxJ, Van der LindenM, NuechterleinKH, et al.A direct examination of the cognitive underpinnings of multitasking abilities: A first study examining schizophrenia. Psychiatry Res, 2018; 268:288–296; doi: 10.1016/j.psychres.2018.06.060
31.
HanK, Young KimI, KimJJ. Assessment of cognitive flexibility in real life using virtual reality: A comparison of healthy individuals and schizophrenia patients. Comput Biol Med, 2012; 42(8):841–847; doi: 10.1016/j.compbiomed.2012.06.007
32.
HoltDV, RodewaldK, RentropM, et al.The plan-a-day approach to measuring planning ability in patients with schizophrenia. J Int Neuropsychol Soc, 2011; 17(2):327–335; doi: 10.1017/S1355617710001712
33.
AubinG, BéliveauMF, KlingerE. An exploration of the ecological validity of the Virtual Action Planning-Supermarket (VAP-S) with people with schizophrenia. Neuropsychol Rehabil, 2018; 28(5):689–708; doi: 10.1080/09602011.2015.1074083
34.
SiemerkusJ, IrleE, Schmidt-SamoaC, et al.Egocentric spatial learning in schizophrenia investigated with functional magnetic resonance imaging. Neuroimage Clin, 2012; 1(1):153–163; doi: 10.1016/J.NICL.2012.10.004
35.
ManDWK, GanesanB, YipCCK, et al.Validation of the virtual-reality prospective memory test (Hong Kong Chinese version) for individuals with first-episode schizophrenia. Neuropsychol Rehabil, 2018; 28(7):1197–1210; doi: 10.1080/09602011.2016.1251949
36.
GallegoJA, NielsenJ, De HertM, et al.Safety and tolerability of antipsychotic polypharmacy. Expert Opin Drug Saf, 2012; 11(4):527–542; doi: 10.1517/14740338.2012.683523
37.
MosolovSN, YaltonskayaPA. Primary and secondary negative symptoms in schizophrenia. Front Psychiatry, 2021; 12:766692; doi: 10.3389/FPSYT.2021.766692
38.
ParsonsTD, CarlewAR, MagtotoJ, et al.The potential of function-led virtual environments for ecologically valid measures of executive function in experimental and clinical neuropsychology. Neuropsychol Rehabil, 2017; 27(5):777–807; doi: 10.1080/09602011.2015.1109524
39.
Chicchi GiglioliIA, Bermejo VidalC, Alcañiz RayaM. A virtual versus an augmented reality cooking task based tools: A behavioral and physiological study on the assessment of executive functions. Front Psychol, 2019; 10:2529–2512; doi: 10.3389/fpsyg.2019.02529
40.
Chicchi GiglioliI, Pérez GálvezB, Gil GranadosA, et al.The virtual cooking task: A preliminary comparison between neuropsychological and ecological virtual reality tests to assess executive functions alterations in patients affected by alcohol use disorder. Cyberpsychol Behav Soc Netw, 2021; 24(10):673–682; doi: 10.1089/cyber.2020.0560
41.
MiskowiakKW, JespersenAE, KessingLV, et al.Cognition assessment in virtual reality: Validity and feasibility of a novel virtual reality test for real-life cognitive functions in mood disorders and psychosis spectrum disorders. J Psychiatr Res, 2022; 145:182–189; doi: 10.1016/j.jpsychires.2021.12.002
42.
FettAKJ, ReichenbergA, VelthorstE. Lifespan evolution of neurocognitive impairment in schizophrenia—A narrative review. Schizophr Res Cogn, 2022; 28:100237; doi: 10.1016/j.scog.2022.100237
43.
RehseM, BartolovicM, BaumK, et al.Influence of antipsychotic and anticholinergic loads on cognitive functions in patients with schizophrenia. Schizophr Res Treatment, 2016; 2016:8213165; doi: 10.1155/2016/8213165
44.
American Psychiatric Association. Diagnostic and Statistical Manual of Mental Disorders, Fifth Edition. American Psychiatric Association; Virginia. 2013; doi: 10.1176/appi.books.9780890425596
45.
FirstMB. Structured Clinical Interview for the DSM (SCID). In: The Encyclopedia of Clinical Psychology. John Wiley & Sons; New York. 2015; pp. 1–6; doi: 10.1002/9781118625392.wbecp351
46.
RosaAR, Sánchez-MorenoJ, Martínez-AranA, et al.Validity and reliability of the Functioning Assessment Short Test (FAST) in bipolar disorder. Clin Pract Epidemiol Ment Health, 2007; 3:5; doi: 10.1186/1745-0179-3-5
47.
LinCH, LinHS, LinSC, et al.Early improvement in PANSS-30, PANSS-8, and PANSS-6 scores predicts ultimate response and remission during acute treatment of schizophrenia. Acta Psychiatr Scand, 2018; 137(2):98–108; doi: 10.1111/acps.12849
48.
Cervera-TorresS, Ruiz-FernándezS, GodbersenH, et al.Influence of resilience and optimism on distress and intention to self-isolate: Contrasting lower and higher COVID-19 illness risk samples from an extended health belief model. Front Psychol, 2021; 12:662395–662310; doi: 10.3389/fpsyg.2021.662395
ConoverWJ, ImanRL. Analysis of covariance using the rank transformation. Biometrics, 1982; 38(3):715–724.
51.
FernándezSR, KastnerL, Cervera-TorresS, et al.Moved by emotions: Affective concepts representing personal life events induce freely performed steps in line with combined sagittal and lateral space-valence associations. Front Psychol, 2019; 10:2787–2713; doi: 10.3389/fpsyg.2019.02787
52.
GaoQ, JiaG, ZhaoJ, et al.Inhibitory control in excessive social networking users: Evidence from an event-related potential-based go-nogo task. Front Psychol, 2019; 10:1810; doi: 10.3389/fpsyg.2019.01810
53.
PerryRE, BrarenSH, Rincón-CortésM, et al.Enhancing executive functions through social interactions: Causal evidence using a cross-species model. Front Psychol, 2019; 10:2472–2411; doi: 10.3389/fpsyg.2019.02472
54.
PinkhamAE, PennDL. Neurocognitive and social cognitive predictors of interpersonal skill in schizophrenia. Psychiatry Res, 2006; 143(2–3):167–178; doi: 10.1016/j.psychres.2005.09.005
55.
LiebermanJA. Is schizophrenia a neurodegenerative disorder? A clinical and neurobiological perspective. Biol Psychiatry, 1999; 46(6):729–739; doi: 10.1016/S0006-3223(99)00147-X
56.
LewandowskiKE, CohenBM, ÖngurD. Evolution of neuropsychological dysfunction during the course of Schizophrenia and bipolar disorder. Psychol Med, 2011; 41(2):225–241; doi: 10.1017/S0033291710001042
57.
ZhangY, FangX, FanW, et al.Brain-derived neurotrophic factor as a biomarker for cognitive recovery in acute schizophrenia: 12-week results from a prospective longitudinal study. Psychopharmacology (Berl), 2018; 235(4):1191–1198; doi: 10.1007/s00213-018-4835-6
58.
FuscoA, TieriG. Challenges and perspectives for clinical applications of immersive and non-immersive virtual reality. J Clin Med, 2022; 11(15); doi: 10.3390/jcm11154540
59.
CrossleyNA, AlliendeLM, CzepielewskiLS, et al.The enduring gap in educational attainment in Schizophrenia according to the last 50 years of published research: A meta-analysis. Lancet Psychiatry, 2022; 9(7):565–573; doi: 10.1016/S2215-0366(22)00121-3
Supplementary Material
Please find the following supplemental material available below.
For Open Access articles published under a Creative Commons License, all supplemental material carries the same license as the article it is associated with.
For non-Open Access articles published, all supplemental material carries a non-exclusive license, and permission requests for re-use of supplemental material or any part of supplemental material shall be sent directly to the copyright owner as specified in the copyright notice associated with the article.
